186 related articles for article (PubMed ID: 2442074)
1. Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985.
Marcus RE; Catovsky D; Prentice HG; Newland AC; Chessells JM; Stevens RF; Hann IM; Goldman JM; Hoffbrand AV; Galton DA
Haematol Blood Transfus; 1987; 30():346-51. PubMed ID: 2442074
[No Abstract] [Full Text] [Related]
2. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia.
Rees JK; Gray R; Hayhoe FG
Haematol Blood Transfus; 1987; 30():35-7. PubMed ID: 2442075
[No Abstract] [Full Text] [Related]
3. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
Rees JK; Gray RG
Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
[No Abstract] [Full Text] [Related]
4. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D
Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
[TBL] [Abstract][Full Text] [Related]
5. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report.
Lampkin BC; Woods WG; Buckley JD; Hammond GD
Haematol Blood Transfus; 1990; 33():210-4. PubMed ID: 1691130
[No Abstract] [Full Text] [Related]
8. The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
Creutzig U; Ritter J; Riehm H; Budde M; Schellong G
Haematol Blood Transfus; 1987; 30():71-5. PubMed ID: 3305225
[No Abstract] [Full Text] [Related]
9. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
Creutzig U; Ritter I; Schellong G
Gematol Transfuziol; 1991 Jan; 36(1):16-21. PubMed ID: 2065939
[No Abstract] [Full Text] [Related]
10. A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia.
Kurrle E; Ehninger G; Freund M; Heil G; Hoelzer D; Link H; Mitrou PS; Ohl S; Queisser W; Schlimok G
Blut; 1988 May; 56(5):233-6. PubMed ID: 3285914
[No Abstract] [Full Text] [Related]
11. Therapy of acute myelogenous leukemia in adults.
Petti MC; Broccia G; Caronia F; Di Raimondo F; Fioritoni G; Ladogana S; Leone G; Liso V; Musso M; Neri A
Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417
[No Abstract] [Full Text] [Related]
12. Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapy.
Evensen SA; Brinch L; Stavem P; Tjønnfjord G
J Intern Med; 1992 Nov; 232(5):433-7. PubMed ID: 1453128
[TBL] [Abstract][Full Text] [Related]
13. Prolonged survival in acute myelogenous leukaemia without maintenance chemotherapy.
Champlin R; Jacobs A; Gale RP; Boccia R; Elashoff R; Foon K; Zighelboim J
Lancet; 1984 Apr; 1(8382):894-6. PubMed ID: 6200742
[TBL] [Abstract][Full Text] [Related]
14. Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study.
Marty M; Lepage E; Guy H; Bordessoule D; Desablens B; Harousseau JL; Guilhot F; Leverger G; Schaison G; Boiron M
Haematol Blood Transfus; 1987; 30():50-6. PubMed ID: 3305217
[No Abstract] [Full Text] [Related]
15. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.
Stevens RF; Hann IM; Wheatley K; Gray RG
Br J Haematol; 1998 Apr; 101(1):130-40. PubMed ID: 9576193
[TBL] [Abstract][Full Text] [Related]
16. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
Rees JK; Gray RG; Swirsky D; Hayhoe FG
Lancet; 1986 Nov; 2(8518):1236-41. PubMed ID: 2878130
[TBL] [Abstract][Full Text] [Related]
17. Amsacrine, cytarabine and etoposide in the treatment of bad prognosis acute myeloid leukemia.
Wahlin A
Med Oncol Tumor Pharmacother; 1989; 6(3):199-205. PubMed ID: 2615524
[TBL] [Abstract][Full Text] [Related]
18. Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
Tan RM; Quah TC; Aung L; Liang S; Kirk RC; Yeoh AE
Pediatr Blood Cancer; 2007 Mar; 48(3):262-7. PubMed ID: 16602120
[TBL] [Abstract][Full Text] [Related]
19. Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
Zittoun R; Liso V; Mandelli F; Rotoli B; de Witte T; Gattringer C; Resegotti L; Caronia F; Leoni P; Petti MC
Leukemia; 1992; 6 Suppl 2():76-7. PubMed ID: 1578949
[No Abstract] [Full Text] [Related]
20. Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
Harousseau JL; Milpied N; Briere J; Desablens B; Le Prise PY; Ifrah N; Gandhour C; Casassus P
Haematol Blood Transfus; 1990; 33():299-303. PubMed ID: 2323633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
